Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism.

Nuria VilarrasaAmador García Ruiz de GordejuelaAnna CasajoanaXevi DuranSilvia ToroEduard EspinetManoel GalvaoJoan VendrellRafael López-UrdialesManuel PérezJordi Pujol

Published in: Obesity surgery (2017)

Endobarrier® in T2DM patients with grade I obesity and poor metabolic control is associated with significant weight decrease and moderate reduction in HbA1c at month 12. Our data do not support a role for GLP-1 in the metabolic improvement in this subset of patients.

Keyphrases

type diabetes
weight loss
metabolic syndrome
end stage renal disease
insulin resistance
ejection fraction
newly diagnosed
glycemic control
chronic kidney disease
weight gain
adipose tissue
cardiovascular disease
physical activity
bariatric surgery
prognostic factors
big data
obese patients
patient reported outcomes